Key facts
- Notable investors include Bailey Biofund.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Rock BioMedical
- ·The full record, as it builds
Funding rounds
No funding rounds for Rock BioMedical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Rock BioMedical
Developer of a saccharification-engineering and AI platform designed for optimizing functional sugar molecules and drug design. The company provides Academia Sinica-licensed technology and AI computation, enabling healthcare industry users to build safer, more effective therapy solutions.
- Sector
- Healthcare
- HQ
- Taipei, Taiwan
- Founded
- 2021
- Website
- rockbiomedical.com.tw/
- Ownership
- Privately Held (backing)
Rock BioMedical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Rock BioMedical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Rock BioMedical in its N-PORT filings yet. We sweep new filings monthly.